Sam Salek

Emailm.s.salekherts.acuk

Research activity per year

Fingerprint

Dive into the research topics where Sam Salek is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

5 Finished

Evaluation of the East African Community Medical Products Joint Regulatory Review System: to improve the Regulatory Assessment Process and Patients’ Access to Medicines
Salek, S. (PI)
1/08/21 → 31/12/24
Project: Research
PPSCDM: A communication aid system based on patient preference to improve shared clinical decision making and treatments outcomes for Parkinson Disease (PD)
Salek, S. (PI), Raha, S. (CoI), Mohamed, B. (CoI), Thomas, C. (CoI), Ebenezer, L. (CoI) & Johns, J. (Researcher)
1/01/19 → 1/01/22
Project: Research
Development of a decision-making framework for improving quality of decision-making during medicines development, regulatory review and health technology assessment
Salek, S. (PI)
Centre for Innovation in Regulatory Science (CIRS)
1/06/15 → 30/05/19
Project: Research
Treatment-Related Patient-2015-06-01 Reported Outcome Measure in Haematological Malignancies for use in Clinical Practice
Salek, S. (PI)
The European Hematology Association (EHA)
1/06/15 → 30/05/18
Project: Research
Development of decision making framework for improving quality of decision making during medicines development, regulatory review and health technology assessment
Salek, S. (PI)
1/06/15 → 30/05/18
Project: Research

108 Article
20 Review article
10 Book
8 Chapter
More

Validation of the FROM-16 in family members of patients receiving advanced therapy medicinal product (ATMP)
Brilliant, C. D., Finlay, A. Y., Salek, S. M., Shah, R., Bacon, E. & Laing, H., 1 Apr 2025, In: Quality of Life Research. 34, 4, p. 949-962 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
7 Downloads (Pure)
Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting
Chan, S. H. Y., Layton, D., Webley, S., Salek, S. & Goto, A. (Editor), 18 Dec 2024, In: Cancers. 16, 24, 14 p., 4223.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Downloads (Pure)
Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16)
Shah, R., Finlay, A. Y., Salek, M. S., Allen, H., Nixon, S. J., Nixon, M., Otwombe, K., Ali, F. M. & Ingram, J. R., 26 Mar 2024, (E-pub ahead of print) In: Journal of Patient-Reported Outcomes. 8, 1, 16 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
9 Downloads (Pure)
Development of a Consumer Reported Outcome Measure for Personal Care Products : The Rationale
Falcone, R., Umaru, N., michniak-kohn, B. & Salek, S., 30 Jan 2024, In: International Journal of Scientific & Technology Research (IJSTR). 11, 1, p. 526-533 10 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
23 Downloads (Pure)
Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African medicines agency
Ngum, N., Ndomondo-Sigonda, M., Walker, S. & Salek, S., 31 Dec 2023, In: Regulatory Toxicology and Pharmacology. 145, p. 1-8 8 p., 105497.
Research output: Contribution to journal › Article › peer-review

Professor Sam Salek

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Evaluation of the East African Community Medical Products Joint Regulatory Review System: to improve the Regulatory Assessment Process and Patients’ Access to Medicines

PPSCDM: A communication aid system based on patient preference to improve shared clinical decision making and treatments outcomes for Parkinson Disease (PD)

Development of a decision-making framework for improving quality of decision-making during medicines development, regulatory review and health technology assessment

Treatment-Related Patient-2015-06-01 Reported Outcome Measure in Haematological Malignancies for use in Clinical Practice

Development of decision making framework for improving quality of decision making during medicines development, regulatory review and health technology assessment

Validation of the FROM-16 in family members of patients receiving advanced therapy medicinal product (ATMP)

Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting

Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16)

Development of a Consumer Reported Outcome Measure for Personal Care Products : The Rationale

Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African medicines agency

Professor Sam Salek

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output